0001213900-20-030221.txt : 20201006 0001213900-20-030221.hdr.sgml : 20201006 20201006104246 ACCESSION NUMBER: 0001213900-20-030221 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20200924 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201006 DATE AS OF CHANGE: 20201006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silo Pharma, Inc. CENTRAL INDEX KEY: 0001514183 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 462137136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54872 FILM NUMBER: 201225858 BUSINESS ADDRESS: STREET 1: 1086 TEANECK ROAD STREET 2: SUITE 3A CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: (718) 400-9031 MAIL ADDRESS: STREET 1: 1086 TEANECK ROAD STREET 2: SUITE 3A CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: Uppercut Brands, Inc. DATE OF NAME CHANGE: 20190808 FORMER COMPANY: FORMER CONFORMED NAME: Point Capital, Inc. DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: Gold Swap Inc DATE OF NAME CHANGE: 20110301 8-K 1 ea127840-8k_silopharma.htm CURRENT REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 24, 2020

 

SILO PHARMA, INC.

(Name of registrant in its charter)

 

Delaware   000-54872   27-3046338
(State or jurisdiction of   (Commission File   (IRS Employer
incorporation or organization)   Number)   Identification No.) 

 

560 Sylvan Ave, Suite 3160

Englewood Cliffs NJ 07632

(Address of principal executive offices)

 

(718) 400-9031

(Registrant’s telephone number)

 

Uppercut Brands Inc.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instructions A.2 below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Appointment of Directors

 

Effective October 1, 2020, the board of directors (the “Board”) of Silo Pharma, Inc. (the “Company”) appointed Dr. Kevin Muñoz as a director of the Company to fill a vacancy on the Board. The board of directors has determined Dr. Muñoz is independent in accordance with the applicable rules of the Nasdaq Stock Market LLC. Dr. Muñoz will serve on the Board’s Audit and Compensation Committees.

 

Dr. Muñoz was not selected as a director pursuant to any arrangements or understandings with the Company or with any other person, and there are no related party transactions between Dr. Muñoz and the Company that would require disclosure under Item 404(a) of Regulation S-K.

 

Set forth below is the biographical information of Dr. Muñoz, as required by Item 401 of Regulation S-K.

 

Dr. Kevin Muñoz, 42, is currently the Director of Operations at Physical Medicine and Rehabilitation, an outpatient facility for the treatment of musculoskeletal issues, and has served in various capacities with Physical Medicine and Rehabilitation since 2008. Dr. Muñoz holds an MD from Xavier University School of Medicine and a BS from the University of Michigan.

 

Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

Change of Name

 

On September 24, 2020, the Company filed with the Delaware Secretary of State a certificate of amendment (the “Amendment”) to the Company’s Certificate of Incorporation to change the legal name of the Company from “Uppercut Brands Inc.” to “Silo Pharma, Inc.” A copy of the Amendment effecting the name change, as filed with the Delaware Secretary of State is attached hereto as Exhibit 3.1.

 

Item 8.01Other Events.

 

On September 28, 2020, the Company issued a press release announcing its name change to Silo Pharma, Inc., a copy of which is filed as Exhibit 99.1.

 

On October 6, 2020, the Company issued a press release announcing the appointment of Dr. Kevin Muñoz, MD to the Company’s Board of Directors, a copy of which is filed as Exhibit 99.1.

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits

 

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

 

Exhibit
Number

  Description
3.1   Certificate of Amendment filed with the Delaware Secretary of State on September 24, 2020
99.1   Press Release dated September 28, 2020
99.2   Press Release dated October 6, 2020

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SILO PHARMA, INC.
     
Date: October 6, 2020 By: /s/ Eric Weisblum
   

Eric Weisblum,

Chief Executive Officer

 

 

2

 

 

EX-3.1 2 ea127840ex3-1_silopharma.htm CERTIFICATE OF AMENDMENT FILED WITH THE DELAWARE SECRETARY OF STATE ON SEPTEMBER 24, 2020

Exhibit 3.1

 

 

EX-99.1 3 ea127840ex99-1_silopharma.htm PRESS RELEASE DATED SEPTEMBER 28, 2020

Exhibit 99.1

 

 

 

Uppercut Brands, Inc. Changes Name to Silo Pharma, Inc.; reflecting Company’s Emerging Focusing on the Development and Commercialization of Psychedelic/Psilocybin-based Drug Therapies

Early Entrant, Addressing Massive Market Opportunity for Psychedelic Drug Therapies
for a Wide-Range of Conditions, Including PTSD and Parkinson’s Disease;

Company to Trade Under New Symbol SILO

NEW YORK , Sept. 28, 2020 (GLOBE NEWSWIRE) -- Uppercuts Brands, Inc. (OTC Pink: UCUT) today announced that it has completed its name change to Silo Pharma, Inc. (“Silo” or “the Company”) and will trade under the stock ticker symbol SILO effective today.

“This name change is a significant step in our transformation to a biopharmaceutical company focused on the development and commercialization of disruptive psychedelic drug therapies,” commented Eric Weisblum, Silo Pharma’s Chief Executive Officer. “As one of the first US publicly-traded entrants into the emerging psilocybin-based drug market, we are pursuing opportunities to sponsor clinical research and subsequently license drug therapies for the treatment of major emotional disturbances such as PTSD, depression, anxiety and addiction as well as other neurological disorders such as Alzheimer’s and Parkinson’s.”

Weisblum continued, “Now more than ever, creative new therapies are needed to address the growing mental health challenges that are being further exacerbated by turbulent economic conditions and the recent global health crisis.  Early lab studies with psychedelic drugs, like psilocybin, have shown promising indications producing neurological responses that could potentially treat a wide variety of emotional and neurological disorders. We are pursuing multiple opportunities to partner with leading medical universities to license and/or develop assets based upon psychedelic drug therapies that could be transformative to the health and well-being of patients. Our business is well-capitalized, and we believe that combining our resources with leading medical researchers will lead to significant advances in the psychedelic category.”

“The FDA has recently granted ‘Breakthrough Therapy Designations’ for a number of psychedelic based therapies, accelerating the clinical process, and with decriminalization just beginning, we believe that we are well-positioned at the forefront of an enormous and emerging opportunity,” added Weisblum. “In the coming weeks and months, we will be updating investors with additions to our scientific advisory board, sponsored research/licensing deals with universities and an uplisting to the OTCQB Market.”

 

 

About Silo Pharma

Silo Pharma is an early stage biopharmaceutical company focused on the use of psychedelic proprietary therapeutics for patients suffering from indications such as depression, PTSD, Alzheimer’s and other rare neurological disorders.  For more information, visit www.silopharma.com 

Safe Harbor and Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of words “could”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “may”, “continue”, “predict”, “potential” and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of Silo Pharma, Inc. (“Silo” or “the Company”) to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company’s technology platforms, retaining and expanding the Company’s customer base, fluctuations in consumer spending on the Company’s products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this presentation, whether as a result of new information, future events or otherwise, after the date of this presentation or to reflect the occurrence of unanticipated events except as required by law.

Company Contact: Investor Relations Contact:
SiloPharma, Inc. Hayden IR
Eric Weisblum, CEO Brett Maas
718-498-9890 646-536-7331
Email: eric@silopharma.com Email: brett@haydenir.com

 

 

 

EX-99.2 4 ea127840ex99-2_silopharma.htm PRESS RELEASE DATED OCTOBER 6, 2020

Exhibit 99.2

 

 

Silo Pharma, Inc. Expands Board with Appointment of Dr. Kevin Muñoz MD;

Announces Application to Uplist to OTCQB Market

 

NEW YORK – October 6, 2020 – Silo Pharma, Inc. (OTC Pink: SILO), which recently announced its transformation to a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced the appointment of Dr. Kevin Muñoz, MD, to its Board of Directors effective October 1, 2020. In addition, the Company filed an application with the OTC Markets Group, Inc. on September 22, 2020 to uplist from the OTC Pink Open Market to the OTCQB Venture Market tier.

 

“Dr. Munoz has a strong working knowledge of healthcare operations with more than 15 years in the field including clinical research,” said Eric Weisblum, CEO of Silo Pharma. “Through his professional experiences, he has demonstrated a proven ability to collaborate and improve operational processes to elevate the quality of patient care. We look forward to leveraging his expertise and broad experience to further our mission. Kevin’s experience with “big data” will also help us target the proper indications and patient population that would benefit from psilocybin-based therapeutics.”

 

Dr. Muñoz currently serves as Director of Operations at Physical Medicine and Rehabilitation where he has responsibility for the day-to-day management of all office operations with a focus on ensuring and increasing patient satisfaction. Prior to that, he led the configuration efforts during an enterprise-wide implementation of application software that also included streamlining and improving business processes. Kevin began his career with Harlem Health Promotion Center in New York City as a Research Assistant where he was responsible for data collection and interpretation. Dr. Muñoz earned a Bachelor of Science from the University of Michigan where he graduated with distinction and a Doctor of Medicine from Xavier University School of Medicine, Aruba NA.

 

“Moving to a higher OTC Market tier will provide us with greater visibility within the investment community and with stakeholders as we pursue new opportunities for investment in psychedelic drug research including psilocybin,” added Weisblum. “A listing on OTCQB significantly broadens the universe of potential investors in the Company. Historically, companies that have made the move up to the OTCQB tier have experienced an increase in liquidity and access to investment capital.”

 

The Company intends to move expeditiously to secure the listing on the OTCQB Venture Market tier, which remains subject to OTC Market approval.

 

About Silo Pharma

 

Silo Pharma is an early stage biopharmaceutical company that has recently began to focus on the development and use of assets and therapies involving the use of drugs, such as psilocybin or LSD, for patients suffering from indications such as depression, PTSD, Parkinson’s and other rare neurological disorders. For more information, visit www.silopharma.com

 

Safe Harbor and Forward-Looking Statements

 

This news release contains "forward-looking statements" within the meaning of the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of words “could”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “may”, “continue”, “predict”, “potential” and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of Silo Pharma, Inc. (“Silo” or “the Company”) to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company’s technology platforms, retaining and expanding the Company’s customer base, fluctuations in consumer spending on the Company’s products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this presentation, whether as a result of new information, future events or otherwise, after the date of this presentation or to reflect the occurrence of unanticipated events except as required by law.

 

Company Contact: Investor Relations Contact:
Silo Pharma, Inc. Hayden IR
Eric Weisblum, CEO Brett Maas
718-498-9890 646-536-7331
Email: eric@silopharma.com Email: brett@haydenir.com

 

GRAPHIC 5 ex99-2_001.jpg GRAPHIC begin 644 ex99-2_001.jpg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image_001.jpg GRAPHIC begin 644 image_001.jpg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�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�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